Notes - Segment Information, Etc.

SAPPORO CLINICAL LABORATORY INC. - Filing #7247539

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
11,339,952,000 JPY
19,965,562,000 JPY
165,810,000 JPY
7,752,103,000 JPY
20,131,372,000 JPY
873,506,000 JPY
11,058,660,000 JPY
936,757,000 JPY
19,556,619,000 JPY
7,561,201,000 JPY
125,700,000 JPY
19,682,319,000 JPY
Transactions with other segments
JPY
719,115,000 JPY
9,570,000 JPY
JPY
728,686,000 JPY
719,115,000 JPY
JPY
625,848,000 JPY
625,848,000 JPY
JPY
5,796,000 JPY
631,644,000 JPY
Other items
Depreciation
114,697,000 JPY
422,317,000 JPY
5,148,000 JPY
297,648,000 JPY
427,466,000 JPY
9,971,000 JPY
108,574,000 JPY
8,291,000 JPY
400,951,000 JPY
284,085,000 JPY
2,214,000 JPY
403,165,000 JPY
Increase in property, plant and equipment and intangible assets
154,463,000 JPY
436,573,000 JPY
13,912,000 JPY
279,286,000 JPY
450,485,000 JPY
2,823,000 JPY
193,459,000 JPY
24,841,000 JPY
342,408,000 JPY
124,106,000 JPY
4,035,000 JPY
346,444,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.